Skip to main content
    • Aa
    • Aa

Dopaminergic imaging: clinical utility now and in the future

  • Zuzana Walker (a1) and Joanne Rodda (a2)

Over the past ten years, dopaminergic imaging has become increasingly part of the assessment and diagnosis of dementia. There are numerous PET and SPECT ligands available that target different steps in the process of neurotransmission. Abnormalities in dopaminergic imaging measures are consistent features of dementia with Lewy bodies (DLB) and other parkinsonian syndromes, and can be used to facilitate diagnosis, particularly in distinguishing between DLB and Alzheimer's disease. This review summarizes present knowledge in this area and the implications for current and future clinical practice.

Corresponding author
Correspondence should be addressed to: Zuzana Walker, MD, FRCPsych, University College London and North Essex Partnership NHS Foundation Trust, Mental Health Unit, St Margaret's Hospital, The Plain, Epping, Essex, CM16 6TN, UK. Phone: +44 1279-827-893; Fax: +44 1992-571-089. Email:
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Psychogeriatrics
  • ISSN: 1041-6102
  • EISSN: 1741-203X
  • URL: /core/journals/international-psychogeriatrics
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Altmetric attention score

Full text views

Total number of HTML views: 1
Total number of PDF views: 11 *
Loading metrics...

Abstract views

Total abstract views: 80 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 17th October 2017. This data will be updated every 24 hours.